Daily Dosing of Rifapentine Cures Tuberculosis in Three Months or Less in the Murine Model

BACKGROUND: Availability of an ultra-short-course drug regimen capable of curing patients with tuberculosis in 2 to 3 mo would significantly improve global control efforts. Because immediate prospects for novel treatment-shortening drugs remain uncertain, we examined whether better use of existing d...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenthal, Ian M, Zhang, Ming, Williams, Kathy N, Peloquin, Charles A, Tyagi, Sandeep, Vernon, Andrew A, Bishai, William R, Chaisson, Richard E, Grosset, Jacques H, Nuermberger, Eric L
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2140085/
https://www.ncbi.nlm.nih.gov/pubmed/18092886
http://dx.doi.org/10.1371/journal.pmed.0040344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2140085/
https://www.ncbi.nlm.nih.gov/pubmed/18092886
http://dx.doi.org/10.1371/journal.pmed.0040344

Ejemplares similares